Taiyen Biotech Co., Ltd.
Research Taiyen Biotech Co., Ltd. (1737.TW) on Bullrun: market cap TWD 6.03B, P/E 15.5, dividend yield 4.7%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker1737.TW
- ExchangeTW
- CountryTaiwan
- SectorConsumer Defensive
- IndustryHousehold & Personal Products
- CurrencyTWD
- Market capTWD 6.03B
- P/E15.5
- Dividend yield4.7%
- Financial periodQ2 2026
- RevenueTWD 769.01M
- Net incomeTWD 79.62M
- Free cash flowTWD 77.46M
- Gross margin38.1%
Valuation Snapshot
latest market cap is TWD 6.03B; P/E is 15.5; dividend yield is 4.7%.
Peer valuation comparison
Latest P/E is 15.54x versus a Consumer Defensive sector median of 16.8x (7.5% below).
Latest dividend yield is 4.71% versus a Consumer Defensive sector median of 2.98% (58.1% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 6.03B | 15.5 | 4.6% | 1.4 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1.4 TWD, yield 4.7%.
About Taiyen Biotech Co., Ltd.
Taiyen Biotech Co., Ltd. engages in the production and sale of salt products in Taiwan and internationally. It offers seawater chemicals; toothpaste, mouthwashes, and eyeglass solutions; beverages; bottled water; medical supplies; food and food additives; beauty, skincare, and cleaning products; and salt products; as well as health food and health products. The company was founded in 1952 and is based in Tainan City, Taiwan.
ETFs that hold Taiyen Biotech Co., Ltd.
US-listed ETFs
Taiyen Biotech Co., Ltd. is held by 12 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:
| ETF | Weight | Fee |
|---|---|---|
| Vanguard Total International Stock Index Fund ETF Shares (VXUS) | <0.01% | 0.05% |
| Vanguard FTSE Emerging Markets Index Fund ETF Shares (VWO) | <0.01% | 0.06% |
| Vanguard Total World Stock Index Fund ETF Shares (VT) | <0.01% | 0.06% |
| Avantis Emerging Markets Equity ETF (AVEM) | <0.01% | 0.33% |
| State Street SPDR Portfolio Emerging Markets ETF (SPEM) | 0.02% | 0.07% |
| Vanguard FTSE All-World ex-US Small-Cap Index Fund ETF Shares (VSS) | <0.01% | 0.06% |
| Dimensional Emerging Core Equity Market ETF (DFAE) | <0.01% | 0.29% |
| Dimensional Emerging Markets Core Equity 2 ETF (DFEM) | <0.01% | 0.39% |
Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Consumer Defensive stocks
Frequently asked questions
What is Taiyen Biotech Co., Ltd.'s market cap?
Taiyen Biotech Co., Ltd.'s market capitalization is TWD 6.03B.
What is Taiyen Biotech Co., Ltd.'s P/E ratio?
Taiyen Biotech Co., Ltd.'s price-to-earnings (P/E) ratio is 15.5.
Does Taiyen Biotech Co., Ltd. pay a dividend?
Taiyen Biotech Co., Ltd. has a dividend yield of 4.7%.
What does Taiyen Biotech Co., Ltd. do?
Taiyen Biotech Co., Ltd. engages in the production and sale of salt products in Taiwan and internationally. It offers seawater chemicals; toothpaste, mouthwashes, and eyeglass solutions; beverages; bottled water; medical supplies; food and food additives; beauty, skincare, and cleaning products; and salt products; as well as health food and health products. The company was founded in 1952 and is based in Tainan City, Taiwan.